HUP0004362A2 - Karbamazepint vagy származékait tartalmazó parenterális készítmények - Google Patents

Karbamazepint vagy származékait tartalmazó parenterális készítmények

Info

Publication number
HUP0004362A2
HUP0004362A2 HU0004362A HUP0004362A HUP0004362A2 HU P0004362 A2 HUP0004362 A2 HU P0004362A2 HU 0004362 A HU0004362 A HU 0004362A HU P0004362 A HUP0004362 A HU P0004362A HU P0004362 A2 HUP0004362 A2 HU P0004362A2
Authority
HU
Hungary
Prior art keywords
carbamazepine
derivatives
preparations
parenteral formulations
parenteral
Prior art date
Application number
HU0004362A
Other languages
English (en)
Inventor
Peter Van Hoogevest
Original Assignee
Novartis Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag. filed Critical Novartis Ag.
Publication of HUP0004362A2 publication Critical patent/HUP0004362A2/hu
Publication of HUP0004362A3 publication Critical patent/HUP0004362A3/hu
Publication of HU226106B1 publication Critical patent/HU226106B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Abstract

A találmány görcsoldó hatású 5H-dibenz-[b,f]azepin-5-karboxamidokattartalmazó parenterális készítményekre vonatkozik. A készítmények ahatóanyag mellett oldószerként vizet, kívánt esetben társoldószert,antioxidánst, izotóniás anyagokat és az ilyen készítményeknél szokásostovábbi adalékokat tartalmazhatnak. A készítményt előnyösen intravénásadagolásra alkalmas egységdózis formában állítják elő. Ó
HU0004362A 1997-10-09 1998-10-07 Parenteral formulations comprising a carbamazepine derivative HU226106B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721497.7A GB9721497D0 (en) 1997-10-09 1997-10-09 Organic compounds
PCT/EP1998/006382 WO1999018966A1 (en) 1997-10-09 1998-10-07 Parenteral formulations comprising carbamazepine or its derivatives

Publications (3)

Publication Number Publication Date
HUP0004362A2 true HUP0004362A2 (hu) 2001-08-28
HUP0004362A3 HUP0004362A3 (en) 2006-06-28
HU226106B1 HU226106B1 (en) 2008-04-28

Family

ID=10820342

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004362A HU226106B1 (en) 1997-10-09 1998-10-07 Parenteral formulations comprising a carbamazepine derivative

Country Status (32)

Country Link
US (2) US6316417B1 (hu)
EP (1) EP1033988B1 (hu)
JP (2) JP2001519395A (hu)
KR (1) KR100760326B1 (hu)
CN (1) CN1210032C (hu)
AR (1) AR015465A1 (hu)
AT (1) ATE257383T1 (hu)
AU (1) AU748034B2 (hu)
BR (1) BR9812861A (hu)
CA (1) CA2304661C (hu)
CO (2) CO4950520A1 (hu)
CZ (1) CZ298900B6 (hu)
DE (1) DE69821024T2 (hu)
DK (1) DK1033988T3 (hu)
ES (1) ES2214738T3 (hu)
GB (1) GB9721497D0 (hu)
HK (1) HK1031824A1 (hu)
HU (1) HU226106B1 (hu)
ID (1) ID24134A (hu)
IL (1) IL135123A0 (hu)
MY (1) MY122129A (hu)
NO (1) NO327263B1 (hu)
NZ (1) NZ503526A (hu)
PE (1) PE121998A1 (hu)
PL (1) PL192287B1 (hu)
PT (1) PT1033988E (hu)
RU (1) RU2242231C2 (hu)
SK (1) SK286253B6 (hu)
TR (1) TR200000870T2 (hu)
TW (1) TW584563B (hu)
WO (1) WO1999018966A1 (hu)
ZA (1) ZA989183B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
AU2006299501B2 (en) 2005-09-30 2012-11-29 Lundbeck Llc Novel parenteral carbamazepine formulation
US20100204178A1 (en) * 2006-10-02 2010-08-12 James Cloyd Novel parenteral carbamazepine formulation
JP5528708B2 (ja) * 2006-02-09 2014-06-25 参天製薬株式会社 安定な製剤ならびにそれらを調製および使用する方法
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
CN101711739B (zh) * 2008-10-08 2012-07-04 中国人民解放军军事医学科学院毒物药物研究所 卡马西平的口服药物组合物
CN105726466A (zh) * 2014-12-10 2016-07-06 辽宁药联制药有限公司 一种奥卡西平注射剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0435826A1 (de) * 1989-12-27 1991-07-03 Ciba-Geigy Ag Intravenöse Lösungen für Status Epilepticus
ES2081965T3 (es) * 1989-12-27 1996-03-16 Ciba Geigy Ag Dispositivo para homogenizar la distribuccion no homogenea de la luz de un haz de rayos laser.
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
US5231089A (en) * 1991-12-02 1993-07-27 University Of Florida Method of improving oral bioavailability of carbamazepine
FR2702148B1 (fr) 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
US5466683A (en) * 1994-08-25 1995-11-14 Teva Pharmaceutical Industries Ltd. Water-soluble analogs of carbamazepine

Also Published As

Publication number Publication date
CZ20001279A3 (cs) 2000-07-12
TR200000870T2 (tr) 2000-10-23
ATE257383T1 (de) 2004-01-15
CA2304661C (en) 2007-12-11
CO4950520A1 (es) 2000-09-01
HUP0004362A3 (en) 2006-06-28
KR100760326B1 (ko) 2007-09-20
DK1033988T3 (da) 2004-04-13
GB9721497D0 (en) 1997-12-10
TW584563B (en) 2004-04-21
RU2242231C2 (ru) 2004-12-20
ES2214738T3 (es) 2004-09-16
AR015465A1 (es) 2001-05-02
HU226106B1 (en) 2008-04-28
IL135123A0 (en) 2001-05-20
NO20001730D0 (no) 2000-04-04
US6316417B1 (en) 2001-11-13
PE121998A1 (es) 1999-12-08
SK5052000A3 (en) 2000-12-11
AU9629898A (en) 1999-05-03
JP2001519395A (ja) 2001-10-23
US6458770B1 (en) 2002-10-01
ZA989183B (en) 1999-04-09
CZ298900B6 (cs) 2008-03-05
PL192287B1 (pl) 2006-09-29
AU748034B2 (en) 2002-05-30
PT1033988E (pt) 2004-05-31
CO5090854A1 (es) 2001-10-30
CA2304661A1 (en) 1999-04-22
EP1033988A1 (en) 2000-09-13
JP2005281314A (ja) 2005-10-13
US20020055503A1 (en) 2002-05-09
BR9812861A (pt) 2000-08-08
NO20001730L (no) 2000-04-04
KR20010072533A (ko) 2001-07-31
HK1031824A1 (en) 2001-06-29
WO1999018966A1 (en) 1999-04-22
MY122129A (en) 2006-03-31
CN1274286A (zh) 2000-11-22
PL339446A1 (en) 2000-12-18
ID24134A (id) 2000-07-06
DE69821024D1 (de) 2004-02-12
NO327263B1 (no) 2009-05-25
CN1210032C (zh) 2005-07-13
DE69821024T2 (de) 2004-10-28
SK286253B6 (sk) 2008-06-06
NZ503526A (en) 2003-01-31
EP1033988B1 (en) 2004-01-07

Similar Documents

Publication Publication Date Title
SE9503143D0 (sv) New preparation
ITRM920476A0 (it) Formulazioni galeniche contenenti ciclosporina.
ATE146360T1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
ATE216590T1 (de) Arzneimittelformulierungen für il-12
EP0693924A4 (en) METHODS OF ADMINISTRATION -i (IN VIVO) OF BIOLOGICAL SUBSTANCES AND COMPOSITIONS USED IN SUCH METHODS
DE69729786D1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
FR2677984B1 (fr) Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
CA2180816A1 (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
FI973828A0 (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
PH30982A (en) Optically active 5H-pyrrolo Ä3,4-bÜ pyrazine derivative, its preparation and pharmaceutical compositions containing it.
DK0758248T3 (da) Formuleringer til faktor IX
ITRM920361A1 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
IL133397A0 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
MY111841A (en) Injectable liposomal pharmaceutical preparations
TR199801861T2 (xx) Farmas�tik olarak yararl� bile�imler.
CA2270177A1 (en) Transdermal administration of ment
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
NO944781L (no) 2,5-diokso-2,5-dihydro-1H-benz(b)azepiner som NMDA-reseptor-antagonister
ZA93821B (en) New derivatives of baccatin III and of 10-deacetyibaccatin III, their preparation and the pharmaceutical compositions which contain them.
KR950007857A (ko) 경구투여용 라파마이신 제제
DE69102704D1 (de) Orales, melatonin enthaltendes arzneimittel.
HUP0004362A2 (hu) Karbamazepint vagy származékait tartalmazó parenterális készítmények
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees